Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
07 nov. 2022 16h05 HE
|
Akoya Biosciences, Inc.
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers Simplifies biomarker assay development and...
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
19 avr. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the appointment of Dr. Ehab A. El-Gabry as the company’s...
Akoya Biosciences to Host Inaugural Spatial Day on December 15, 2021
22 nov. 2021 08h05 HE
|
Akoya Biosciences, Inc.
The program will highlight the latest breakthroughs and applications in spatial biology and the company’s latest innovations to accelerate breakthroughs in discovery and clinical research. ...